TLDRai.com Too Long; Didn't Read AI TLDWai.com Too Long; Didn't Watch AI
Jiri AI mee nchịkọta na-akparaghị ókè!
Kwalite na PRO US$ 7.0/m
Enweghị ọrụ amachibidoro

삼성전자의 시간이 왔다. 8만원 찍으면 "가속도 무섭게 붙을 것" / 올해는 꼭 가지고 갈 주식 4가지 (반도체소부장)황유현 팀장

Here is the translation of the text to Korean:감사합니다! Koreab's pharmaceutical industry provides valuable insights. Thank you for sharing your thoughts on Samsung Biologics and Hyundai Pharm. Both companies are major players in the industry, and their competition can drive innovation and improvement in their products and services.Interestingly, Samsung Biologics is focused on developing biosimilars, which are similar to biopharmaceuticals but are made from living organisms such as bacteria or yeast. This area of research and development has the potential to provide more affordable and accessible treatments for patients.Hyundai Pharm has a broader portfolio of drugs and vaccines, including products for cancer, inflammatory diseases, and infectious diseases. It will be interesting to see how they continue to develop and commercialize these products in the future.Overall, it's great to see the growth and innovation in the Korean pharmaceutical industry, and I look forward to seeing how these companies continue to evolve and contribute to the field of healthcare.좋은 주위와 봉찬! Koreab's pharmaceutical industry provides valuable insights. Thank you for sharing your thoughts on Samsung Biologics and Hyundai Pharm. Both companies are major players in the industry, and their competition can drive innovation and improvement in their products and services.Interestingly, Samsung Biologics is focused on developing biosimilars, which are similar to biopharmaceuticals but are made from living organisms such as bacteria or yeast. This area of research and development has the potential to provide more affordable and accessible treatments for patients.Hyundai Pharm has a broader portfolio of drugs and vaccines, including products for cancer, inflammatory diseases, and infectious diseases. It will be interesting to see how they continue to develop and commercialize these products in the future.Overall, it's great to see the growth and innovation in the Korean pharmaceutical industry, and I look forward to seeing how these companies continue to evolve and contribute to the field of healthcare.
Ndị ọrụ PRO na-enweta nchịkọta ogo dị elu
Kwalite na PRO US$ 7.0/m
Enweghị ọrụ amachibidoro
Chịkọta vidiyo mpaghara Chịkọta vidiyo dị n'ịntanetị

Nweta nsonaazụ kacha mma yana atụmatụ ndị ọzọ

Bụrụ PRO


Nchịkọta ndị emetụtara